| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |